Safety and efficacy of ibrutinib in patients with chronic lymphocytic leukemia: A retrospective study
Latest Information Update: 10 Aug 2021
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 03 Dec 2019 New trial record
- 06 Nov 2019 Results released in the 61st Annual Meeting and Exposition of the American Society of Hematology.